TY - JOUR
T1 - COVID-19 and education
T2 - restructuring after the pandemic
AU - ESOT COVID-19 Working Group
AU - Bellini, Maria Irene
AU - Pengel, Liset
AU - Potena, Luciano
AU - Segantini, Luca
N1 - Publisher Copyright: © 2021 Steunstichting ESOT. Published by John Wiley & Sons Ltd.
PY - 2021/2
Y1 - 2021/2
N2 - COVID-19 challenges to keep a valuable educational offer with lockdown measures and social distancing are reviewed. Scientific Societies had to think of new alternatives to maintain meetings with conversion to a virtual format and development of online resources, rapidly available and broadly accessible. Other in person activities as face-to-face clinics have been substituted by telemedicine; the same happened with surgical training in theatre, given the suspension of most of the operations. Finally, the need to share and communicate in a continuous evolving scenario, has impacted negatively the integrity of peer review process, not following the normal procedures to ensure scientific integrity and reproducibility in the earliest phases of the pandemic.
AB - COVID-19 challenges to keep a valuable educational offer with lockdown measures and social distancing are reviewed. Scientific Societies had to think of new alternatives to maintain meetings with conversion to a virtual format and development of online resources, rapidly available and broadly accessible. Other in person activities as face-to-face clinics have been substituted by telemedicine; the same happened with surgical training in theatre, given the suspension of most of the operations. Finally, the need to share and communicate in a continuous evolving scenario, has impacted negatively the integrity of peer review process, not following the normal procedures to ensure scientific integrity and reproducibility in the earliest phases of the pandemic.
UR - http://www.scopus.com/inward/record.url?scp=85100182954&partnerID=8YFLogxK
U2 - 10.1111/tri.13788
DO - 10.1111/tri.13788
M3 - Review article
C2 - 33205410
AN - SCOPUS:85100182954
SN - 0934-0874
VL - 34
SP - 220
EP - 223
JO - Transplant International
JF - Transplant International
IS - 2
ER -